Plain-English translation of NCT04888975 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing the Dayspring Active Wearable Compression Technology, a wearable device designed to help improve lymph movement and reduce swelling in the arm after lymphatic surgery. The study will evaluate whether this device is safe and effective for people with breast cancer-related arm swelling who have undergone lymph node surgery.
Arm swelling (lymphedema) is a common problem after breast cancer surgery and lymph node removal, and current treatments have limitations. This trial aims to see if a new wearable compression device can help improve lymph flow and reduce swelling more effectively.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will wear the Dayspring compression device on your affected arm after your lymphatic surgery. The trial will track how well the device works at reducing your arm swelling and check for any safety concerns. You'll work with Dr. Nguyen and the study team to monitor your progress over time.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Koya Medical, Inc.
Enrollment target
~20 participants
Started
June 2021
Primary completion
December 2021
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dung Nguyen, MD, PharmD
Koya Medical, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.